PAPER Sooy K, Webster SP, Noble J, Binnie M, Walker BR, Seckl JR, Yau JL
SEARCH RESULTS
330959 RESULTS
PAPER Ehm O, Göritz C, Covic M, Schäffner I, Schwarz TJ, Karaca E, Kempkes B, Kremmer E, Pfrieger FW, Espinosa L, Bigas A, Giachino C, Taylor V, Frisén J, Lie DC
RBPJkappa-dependent signaling is essential for long-term maintenance of neural stem cells in the adult hippocampus.
J Neurosci. 2010 Oct 13;30(41):13794-807. PubMed: 20943920PAPER Anitha M, Nandhu MS, Anju TR, Jes P, Paulose CS
Targeting glutamate mediated excitotoxicity in Huntington's disease: neural progenitors and partial glutamate antagonist--memantine.
Med Hypotheses. 2011 Jan;76(1):138-40. PubMed: 20943326PAPER Bai Y, Dergham P, Nedev H, Xu J, Galan A, Rivera JC, Zhihua S, Mehta HM, Woo SB, Sarunic MV, Neet KE, Saragovi HU
Chronic and acute models of retinal neurodegeneration TrkA activity are neuroprotective whereas p75NTR activity is neurotoxic through a paracrine mechanism.
J Biol Chem. 2010 Dec 10;285(50):39392-400. PubMed: 20943663PAPER Bosco DA, Landers JE
Genetic determinants of amyotrophic lateral sclerosis as therapeutic targets.
CNS Neurol Disord Drug Targets. 2010 Dec;9(6):779-90. PubMed: 20942785PAPER Pruss RM
Phenotypic screening strategies for neurodegenerative diseases: a pathway to discover novel drug candidates and potential disease targets or mechanisms.
CNS Neurol Disord Drug Targets. 2010 Dec;9(6):693-700. PubMed: 20942792PAPER Vohra BP, Sasaki Y, Miller BR, Chang J, DiAntonio A, Milbrandt J
Amyloid precursor protein cleavage-dependent and-independent axonal degeneration programs share a common nicotinamide mononucleotide adenylyltransferase 1-sensitive pathway.
J Neurosci. 2010 Oct 13;30(41):13729-38. PubMed: 20943913PAPER Butterfield DA, Reed T, Sultana R
Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease.
Free Radic Res. 2011 Jan;45(1):59-72. PubMed: 20942567PAPER Katsarou Z, Bostantjopoulou S, Zikouli A, Kazazi E, Kafantari A, Tsipropoulou V, Kourtesi G, Peitsidou E
Performance of Greek demented and nondemented subjects on the Greek version of the Mattis Dementia Rating Scale. A validation study.
Int J Neurosci. 2010 Nov;120(11):724-30. PubMed: 20942587PAPER Sabayan B, Zamiri N, Farshchizarabi S
Phosphodiesterase-5 inhibitors: novel weapons against Alzheimer's disease?
Int J Neurosci. 2010 Dec;120(12):746-51. PubMed: 20942592PAPER Bandyopadhyay S, Huang X, Lahiri DK, Rogers JT
Novel drug targets based on metallobiology of Alzheimer's disease.
Expert Opin Ther Targets. 2010 Nov;14(11):1177-97. PubMed: 20942746PAPER Diógenes MJ, Outeiro TF
Neurotrophic factors as a protective strategy in Parkinson's disease.
CNS Neurol Disord Drug Targets. 2010 Dec;9(6):754-63. PubMed: 20942787PAPER Badiola N, Suárez-Calvet M, Lleó A
Tau phosphorylation and aggregation as a therapeutic target in tauopathies.
CNS Neurol Disord Drug Targets. 2010 Dec;9(6):727-40. PubMed: 20942789PAPER da Cruz E Silva OA, Henriques AG, Domingues SC, da Cruz E Silva EF
Wnt signalling is a relevant pathway contributing to amyloid beta- peptide-mediated neuropathology in Alzheimer's disease.
CNS Neurol Disord Drug Targets. 2010 Dec;9(6):720-6. PubMed: 20942790PAPER Xilouri M, Stefanis L
Autophagy in the central nervous system: implications for neurodegenerative disorders.
CNS Neurol Disord Drug Targets. 2010 Dec;9(6):701-19. PubMed: 20942791Current Filters
No filters selected